학술논문

Breakthrough SARS-CoV-2 infections after vaccination: a critical review
Document Type
article
Source
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Subject
sars-cov-2
breakthrough
vaccination
covid-19
immunization
Immunologic diseases. Allergy
RC581-607
Therapeutics. Pharmacology
RM1-950
Language
English
ISSN
2164-5515
2164-554X
21645515
Abstract
At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination.